4,5-dimethyl-2-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole
Structure Info
- Chemspace ID
- CSSB00125099171 (In-Stock Building Blocks)
- IUPAC Name
- 4,5-dimethyl-2-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole
- Mol formula
- C15H22BN3O2S
- Mol weight
- 319 Da
- Catalog Number(s)
- BBLS00125099171, BBV-151357223, CSC125099171, EN300-54484572, bbls00125099171
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.35
- Heavy atoms count
- 22
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.6
- Polar surface area (Å)
- 49
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
![Chemical structure of 4,5-dimethyl-2-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole (C15H22BN3O2S) - CSSB00125099171](/st/structure/200/6e62cd01b9958728318788546d3bc921/CC1%253DC%2528C%2529N%253DC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529S1.png "C15H22BN3O2S")
- Zoom the structure
- CSSB00125099171
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2,5-dimethyl-4-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole - CSSB00125100402](/st/structure/200/f71415b8732d9ad81874be47938ba36d/CC1%253DNC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529%253DC%2528C%2529S1.png)
![Chemical structure of 5-bromo-4-methyl-2-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole - CSSB06642255874](/st/structure/200/339eb53f9d9e02668d1d83065b36f5f1/Cc1nc%2528Cn2cc%2528cn2%2529B3OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O3%2529sc1Br.png)
![Chemical structure of 2-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-thiadiazole - CSSB00120463441](/st/structure/200/e687f30b291fbc37d0b492886b2d79c1/CC1%253DNN%253DC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529S1.png)
![Chemical structure of 3-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,2,4-thiadiazole - CSSB00156650914](/st/structure/200/d5046f8016544928d2cf4c17ddc5b37e/CC1%253DNSC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529%253DN1.png)
![Chemical structure of 3-methyl-4-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,2,5-oxadiazole - CSSB00120462225](/st/structure/200/b7ae889e9cefab94db1aa9455d34c22f/CC1%253DNON%253DC1CN1C%253DC%2528C%253DN1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 1-[2-(tert-butylsulfanyl)ethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole - CSSB00120462415](/st/structure/200/a41711e63ef4aabbb80db2ea37047dd9/CC%2528C%2529%2528C%2529SCCN1C%253DC%2528C%253DN1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 1-(2,5-dimethylthiophen-3-yl)-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]ethan-1-one - CSSB21229493925](/st/structure/200/6b91d9dadbd845421a202c8bfb77a29e/CC1%253DCC%2528C%2528%253DO%2529CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529%253DC%2528C%2529S1.png)
